TickerFactsScreenerDevelopers

PALVELLA THERAPEUTICS, INC. (PVLA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $6.33M2013: $3.69M2014: $18.47M2015: $29.35M2016: $29.36M2017: $37.88M2018: $74.87M2019: $62.26M2020: $70.44M2021: $117.76M2022: $38.63M2023: $7.35M2024: $83.60M2025: $57.98M$57.98M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$57.98M-30.6%
2024$83.60M+1037.4%
2023$7.35M-81.0%
2022$38.63M-67.2%
2021$117.76M+67.2%
2020$70.44M+13.1%
2019$62.26M-16.8%
2018$74.87M+97.7%
2017$37.88M+29.0%
2016$29.36M+0.0%
2015$29.35M+58.9%
2014$18.47M+400.7%
2013$3.69M-41.7%
2012$6.33M—